Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Share-based Compensation (2011 - 2026)

Updated

Adma Biologics (ADMA) recorded Share-based Compensation of $6.14 million in Q2 2026, up 23.6% from $4.96 million a year earlier but down 3.1% from the prior quarter.

Analysis

Adma Biologics (ADMA) Share-based Compensation (2011 - 2026) Analysis & Trends

On a TTM basis, Adma Biologics' Share-based Compensation came in at $22.9 million as of Jun 30, 2026, up 25.8% year-over-year; for FY2025, it was $20.03 million, up 47.1% from FY2024.

  • Annual Share-based Compensation has increased for nine straight years, with a five-year compound annual growth rate of 47.6% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $13.62 million in FY2024 (+120.1%), $6.19 million in FY2023 (+18.6%), $5.22 million in FY2022 (+49.5%) and $3.49 million in FY2021 (+22.2%).
  • Quarterly Share-based Compensation has ranged from $688,274 in Q3 2021 to $6.33 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Share-based Compensation rose in seven of the last eight quarters, with growth averaging 75.8%.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 211.3% in Q4 2024, against a decline of 32.4% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.33 million (Q1 2026), $5.39 million (Q4 2025) and $5.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 6.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.14 Mn
Mar 31, 2026 6.33 Mn
Dec 31, 2025 5.39 Mn
Sep 30, 2025 5.05 Mn
Jun 30, 2025 4.96 Mn
Mar 31, 2025 4.62 Mn
Dec 31, 2024 5.43 Mn
Sep 30, 2024 3.18 Mn
Jun 30, 2024 2.86 Mn
Mar 31, 2024 2.14 Mn
Dec 31, 2023 1.75 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.64 Mn
Mar 31, 2023 1.11 Mn
Dec 31, 2022 1.07 Mn
Sep 30, 2022 1.31 Mn
Jun 30, 2022 1.19 Mn
Mar 31, 2022 1.64 Mn
Dec 31, 2021 1.21 Mn
Sep 30, 2021 688,274.00
API Access

Adma Biologics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ADMA&period=max&api_key=YOUR_API_KEY